Latest Breaking News On - Johnson johnsonspinoff - Page 1 : comparemela.com

UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is mid-single-digit. 

Johnson johnsonspinoffPriya sachdevaKenvue incDanielle antalffyTrung huynh